MA
MBA Advisors’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $461K | Buy |
19,037
+932
| +5% | +$22.6K | 0.21% | 86 |
|
|
2025
Q1 | $459K | Buy |
18,105
+7,325
| +68% | +$186K | 0.23% | 80 |
|
|
2024
Q4 | $286K | Sell |
10,780
-1,276
| -11% | -$33.9K | 0.14% | 107 |
|
|
2024
Q3 | $349K | Sell |
12,056
-3,066
| -20% | -$88.7K | 0.17% | 97 |
|
|
2024
Q2 | $423K | Sell |
15,122
-712
| -4% | -$19.9K | 0.22% | 82 |
|
|
2024
Q1 | $439K | Sell |
15,834
-73
| -0.5% | -$2.03K | 0.23% | 80 |
|
|
2023
Q4 | $458K | Sell |
15,907
-1,218
| -7% | -$35.1K | 0.26% | 80 |
|
|
2023
Q3 | $568K | Buy |
17,125
+506
| +3% | +$16.8K | 0.35% | 65 |
|
|
2023
Q2 | $610K | Sell |
16,619
-606
| -4% | -$22.2K | 0.36% | 62 |
|
|
2023
Q1 | $703K | Buy |
17,225
+52
| +0.3% | +$2.12K | 0.44% | 58 |
|
|
2022
Q4 | $880K | Buy |
17,173
+102
| +0.6% | +$5.23K | 0.58% | 48 |
|
|
2022
Q3 | $747K | Buy |
17,071
+2
| +0% | +$88 | 0.54% | 49 |
|
|
2022
Q2 | $895K | Buy |
17,069
+9
| +0.1% | +$472 | 0.62% | 43 |
|
|
2022
Q1 | $883K | Sell |
17,060
-1,250
| -7% | -$64.7K | 0.55% | 52 |
|
|
2021
Q4 | $1.08M | Buy |
18,310
+3,584
| +24% | +$212K | 0.67% | 41 |
|
|
2021
Q3 | $633K | Buy |
14,726
+192
| +1% | +$8.25K | 0.47% | 59 |
|
|
2021
Q2 | $569 | Buy |
14,534
+137
| +1% | +$5 | 0.26% | 68 |
|
|
2021
Q1 | $522 | Buy |
+14,397
| New | +$522 | 0.29% | 68 |
|